Literature DB >> 26823428

Airway acidification initiates host defense abnormalities in cystic fibrosis mice.

Viral S Shah1, David K Meyerholz2, Xiao Xiao Tang3, Leah Reznikov4, Mahmoud Abou Alaiwa4, Sarah E Ernst3, Philip H Karp3, Christine L Wohlford-Lenane5, Kristopher P Heilmann6, Mariah R Leidinger2, Patrick D Allen4, Joseph Zabner4, Paul B McCray7, Lynda S Ostedgaard4, David A Stoltz8, Christoph O Randak5, Michael J Welsh9.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. In humans and pigs, the loss of CFTR impairs respiratory host defenses, causing airway infection. But CF mice are spared. We found that in all three species, CFTR secreted bicarbonate into airway surface liquid. In humans and pigs lacking CFTR, unchecked H(+) secretion by the nongastric H(+)/K(+) adenosine triphosphatase (ATP12A) acidified airway surface liquid, which impaired airway host defenses. In contrast, mouse airways expressed little ATP12A and secreted minimal H(+); consequently, airway surface liquid in CF and non-CF mice had similar pH. Inhibiting ATP12A reversed host defense abnormalities in human and pig airways. Conversely, expressing ATP12A in CF mouse airways acidified airway surface liquid, impaired defenses, and increased airway bacteria. These findings help explain why CF mice are protected from infection and nominate ATP12A as a potential therapeutic target for CF.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26823428      PMCID: PMC4852973          DOI: 10.1126/science.aad5589

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH.

Authors:  S Jayaraman; Y Song; L Vetrivel; L Shankar; A S Verkman
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Protein kinase A-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells: role of Epac I.

Authors:  Nicolas Laroche-Joubert; Sophie Marsy; Stephanie Michelet; Martine Imbert-Teboul; Alain Doucet
Journal:  J Biol Chem       Date:  2002-03-15       Impact factor: 5.157

3.  Airway surface pH in subjects with cystic fibrosis.

Authors:  D McShane; J C Davies; M G Davies; A Bush; D M Geddes; E W F W Alton
Journal:  Eur Respir J       Date:  2003-01       Impact factor: 16.671

4.  Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium.

Authors:  Raymond D Coakley; Barbara R Grubb; Anthony M Paradiso; John T Gatzy; Larry G Johnson; Sylvia M Kreda; Wanda K O'Neal; Richard C Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

5.  Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice.

Authors:  L L Clarke; B R Grubb; J R Yankaskas; C U Cotton; A McKenzie; R C Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Anomalies in ion transport in CF mouse tracheal epithelium.

Authors:  B R Grubb; A M Paradiso; R C Boucher
Journal:  Am J Physiol       Date:  1994-07

Review 7.  Pathophysiology of gene-targeted mouse models for cystic fibrosis.

Authors:  B R Grubb; R C Boucher
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

Review 8.  Physiological basis of cystic fibrosis: a historical perspective.

Authors:  P M Quinton
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

9.  cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia.

Authors:  J J Smith; M J Welsh
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 10.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

View more
  140 in total

Review 1.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

Review 2.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

3.  Sex-specific airway hyperreactivity and sex-specific transcriptome remodeling in neonatal piglets challenged with intra-airway acid.

Authors:  Leah R Reznikov; Yan Shin J Liao; Tongjun Gu; Katelyn M Davis; Shin Ping Kuan; Kalina R Atanasova; Joshua S Dadural; Emily N Collins; Maria V Guevara; Kevin Vogt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-08       Impact factor: 5.464

Review 4.  Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.

Authors:  Kevin G Chen; Pingyu Zhong; Wei Zheng; Jeffrey M Beekman
Journal:  Drug Discov Today       Date:  2019-06-04       Impact factor: 7.851

Review 5.  25th Annual Midwest Microbial Pathogenesis Conference

Authors:  Timothy L Yahr; Craig D Ellermeier
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

6.  AJRCCM: 100-Year Anniversary. Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis.

Authors:  Bonnie W Ramsey; Michael J Welsh
Journal:  Am J Respir Crit Care Med       Date:  2017-05-01       Impact factor: 21.405

7.  Concurrent absorption and secretion of airway surface liquids and bicarbonate secretion in human bronchioles.

Authors:  A K M Shamsuddin; Paul M Quinton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-06       Impact factor: 5.464

8.  Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice.

Authors:  Mathilde Beka; Teresinha Leal
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

9.  Acidic Submucosal Gland pH and Elevated Protein Concentration Produce Abnormal Cystic Fibrosis Mucus.

Authors:  Yuliang Xie; Lin Lu; Xiao Xiao Tang; Thomas O Moninger; Tony Jun Huang; David A Stoltz; Michael J Welsh
Journal:  Dev Cell       Date:  2020-07-29       Impact factor: 12.270

10.  CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

Authors:  Benjamin Steines; David D Dickey; Jamie Bergen; Katherine Jda Excoffon; John R Weinstein; Xiaopeng Li; Ziying Yan; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Linda S Powers; Nicholas D Gansemer; Lynda S Ostedgaard; John F Engelhardt; David A Stoltz; Michael J Welsh; Patrick L Sinn; David V Schaffer; Joseph Zabner
Journal:  JCI Insight       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.